Press Releases about Astrazeneca Plc ADR
AstraZeneca Full year and Q4 2023 Financial Results
February 08, 2024
From AstraZeneca
Via Business Wire
Markets suddenly price Eli Lilly stock for a breakout on earnings
February 05, 2024
Via MarketBeat
From Brodsky & Smith LLC
Via GlobeNewswire
From Brodsky & Smith LLC
Via GlobeNewswire
Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs
January 08, 2024
From Brodsky & Smith LLC
Via GlobeNewswire
From Brodsky & Smith LLC
Via GlobeNewswire
From Brodsky & Smith LLC
Via GlobeNewswire
AstraZeneca advances scientific leadership in hematology at ASH 2023
November 29, 2023
From AstraZeneca
Via Business Wire
Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes $200 Billion GLP-1 Market with its DehydraTECH(TM) Technology
November 14, 2023
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.